Financial Statements

Plus Therapeutics, Inc. (PSTV)

$0.4963

-0.03 (-6.23%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) -434-425-414-402-
Net Income -13-8-11-13-23
Stock Dividends -----379
Dividend Paid -----
Retained Earnings -447-434-425-414-402

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 2333-
Annual Depreciation -0-00-05
Capital Expenditure -0-0-0-0-1
Net PPE 22333

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -4400
New Purchases -----
Intangible and Goodwill 44000

Plus Therapeutics, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Plus Therapeutics, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.